Growth Metrics

Biocryst Pharmaceuticals (BCRX) Assets Average: 2011-2014

Historic Assets Average for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Dec 2014 value amounting to $92.9 million.

  • Biocryst Pharmaceuticals' Assets Average rose 3.60% to $144.6 million in Q3 2015 from the same period last year, while for Sep 2015 it was $144.6 million, marking a year-over-year increase of 3.60%. This contributed to the annual value of $92.9 million for FY2014, which is 74.72% up from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Assets Average stood at $92.9 million for FY2014, which was up 74.72% from $53.2 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Assets Average ranged from a high of $95.8 million in FY2011 and a low of $53.2 million during FY2013.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Assets Average value was $69.8 million (recorded in 2012), while the average stood at $71.9 million.
  • Its Assets Average has fluctuated over the past 5 years, first fell by 27.14% in 2012, then skyrocketed by 74.72% in 2014.
  • Over the past 4 years, Biocryst Pharmaceuticals' Assets Average (Yearly) stood at $95.8 million in 2011, then decreased by 27.14% to $69.8 million in 2012, then dropped by 23.88% to $53.2 million in 2013, then surged by 74.72% to $92.9 million in 2014.